For oncology drug manufacturers, it’s crucial to understand what third party pathways are, who creates and uses them, and how and why adherence rates to pathways vary. You’ll also learn how a product’s placement on pathways affects its utilization and uptake, and ultimately, patient’s access to life saving therapies.
Summary: